Literature DB >> 33190738

Risk factors and associated outcomes of hospital readmission in COPD: A systematic review.

Chidiamara M Njoku1, Jaber S Alqahtani2, Barbara C Wimmer3, Gregory M Peterson3, Leigh Kinsman4, John R Hurst5, Bonnie J Bereznicki6.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of unplanned readmission. There is need to identify risk factors for, and strategies to prevent readmission in patients with COPD. AIM: To systematically review and summarise the prevalence, risk factors and outcomes associated with rehospitalisation due to COPD exacerbation.
METHOD: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Five databases were searched for relevant studies.
RESULTS: Fifty-seven studies from 30 countries met the inclusion criteria. The prevalence of COPD-related readmission varied from 2.6 to 82.2% at 30 days, 11.8-44.8% at 31-90 days, 17.9-63.0% at 6 months, and 25.0-87.0% at 12 months post-discharge. There were differences in the reported factors associated with readmissions, which may reflect variations in the local context, such as the availability of community-based services to care for exacerbations of COPD. Hospitalisation in the previous year prior to index admission was the key predictor of COPD-related readmission. Comorbidities (in particular asthma), living in a deprived area and living in or discharge to a nursing home were also associated with readmission. Relative to those without readmissions, readmitted patients had higher in-hospital mortality rates, shorter long-term survival, poorer quality of life, longer hospital stay, increased recurrence of subsequent readmissions, and accounted for greater healthcare costs.
CONCLUSIONS: Hospitalisation in the previous year was the principal risk factor for COPD-related readmissions. Variation in the prevalence and the reported factors associated with COPD-related readmission indicate that risk factors cannot be generalised, and interventions should be tailored to the local healthcare environment.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; Consequences; Readmission; Risk factors

Mesh:

Year:  2020        PMID: 33190738     DOI: 10.1016/j.rmed.2020.105988

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge.

Authors:  Lili Chen; Shiping Chen
Journal:  BMC Pulm Med       Date:  2021-10-15       Impact factor: 3.317

2.  Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study.

Authors:  Swapna Mandal; John R Hurst; Jaber S Alqahtani; Yousef S Aldabayan; Abdulelah M Aldhahir; Ahmad M Al Rajeh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-07

3.  The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD.

Authors:  Jaber S Alqahtani; Ahmad M Al Rajeh; Abdulelah M Aldhahir; Yousef S Aldabayan; John R Hurst; Swapna Mandal
Journal:  ERJ Open Res       Date:  2021-12-20

4.  Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.

Authors:  Murdo Ferguson; Ashwani Kumar Arora; Ilaria Galgani; Margherita Annaratone; Daniela Casula; Gennaro Di Maro; Michel Janssens; Annaelisa Tasciotti; Tino Schwarz
Journal:  Respir Res       Date:  2022-05-04

5.  Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China.

Authors:  Jing Cao; Shengpeng Liu; Juhua Huang
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

6.  Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study.

Authors:  Tingting Xu; Wei Sun; Hongqing Zhao; Xinmin Wang; Qi Yuan; Xijie Zhang; Shan Mao; Xiuwei Zhang; Mingming Zhao; Zebo Sheng; Mingshun Zhang; Mao Huang; Ningfei Ji
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-20

7.  Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.

Authors:  Jaber S Alqahtani; Tope Oyelade; Abdulelah M Aldhahir; Renata Gonçalves Mendes; Saeed M Alghamdi; Marc Miravitlles; Swapna Mandal; John R Hurst
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.